D2P vs Broncholab

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

D2P

by 3D Systems

Broncholab

by Fluidda

AI Verdict

Tool A (D2P) is designed for creating patient-specific 3D anatomical models from various imaging modalities for surgical planning and 3D printing. In contrast, Tool B (Broncholab) specializes in AI-powered functional respiratory imaging from CT scans to provide diagnostic insights into lung function. While both utilize medical imaging and AI, D2P focuses on anatomical reconstruction and visualization for surgical and educational purposes, whereas Broncholab provides functional diagnostic data for pulmonology.

Choose D2P if…

Choose D2P if your primary need is to transform 2D medical images into highly accurate 3D digital or physical anatomical models for surgical planning, custom device design, or patient education. This tool is ideal for specialties like neurosurgery and orthopedics where precise 3D visualization and patient-specific model creation are crucial for complex procedures.

View D2P →

Choose Broncholab if…

Choose Broncholab if you require advanced, regional insights into lung function and disease progression from CT scan data to inform diagnosis and optimize respiratory therapies. This platform is best suited for pulmonologists and radiologists seeking quantitative analysis of lung mechanics and detailed visualization of pulmonary conditions.

View Broncholab →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	D2P	Broncholab
Pricing	Contact for pricing	Contact for pricing
Deployment	Stand-alone modular software package (workstation-based)	SaaS (online platform/web portal)
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

D2P offers a workstation-based software with extensive 3D editing and VR capabilities, providing powerful control for specialized tasks like surgical planning. Broncholab, as a SaaS platform, likely offers easier access and a more streamlined workflow for its specific diagnostic purpose. Both cater to different aspects of usability for their respective user bases.

Clinical Value

Broncholab

Both tools are FDA-cleared and offer significant clinical value. However, Broncholab introduces Functional Respiratory Imaging (FRI), providing novel, detailed regional lung function insights from CT scans that are unavailable through conventional tests, potentially leading to more precise diagnosis and therapy optimization. D2P enhances existing surgical planning workflows with advanced visualization and physical models.

Pricing & Value

Tie

Both D2P and Broncholab have opaque pricing models, requiring direct contact with sales for details. Without publicly available pricing information, it is impossible to conduct a head-to-head comparison of their financial value. Both offer specialized, FDA-cleared solutions that provide significant clinical value in their respective domains.

Enterprise Readiness

Broncholab

Broncholab's SaaS deployment model, explicit HIPAA compliance, and 'likely' BAA make it generally more scalable, easier to manage, and better aligned with enterprise IT requirements. D2P is a workstation-based solution, and while from a large company, its specific HIPAA compliance and BAA for the software are not as explicitly stated in the provided information.

Innovation

Broncholab

D2P innovatively applies deep learning for automatic segmentation and Virtual Reality for advanced visualization in 3D medical modeling. Broncholab's core offering, Functional Respiratory Imaging (FRI), represents a more fundamental innovation in diagnostic imaging by providing a new type of physiological insight into regional lung function from standard CT scans.

Support & Docs

D2P

3D Systems provides extensive public documentation for D2P, including user manuals, installation guides, system requirements, and clear contact channels for support. Information regarding dedicated support portals or detailed documentation for Broncholab is not as readily available or detailed in public sources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	D2P	Broncholab
Primary Use Case	Advanced visualization, surgical planning, and 3D printing of patient-specific models.	Diagnosing and monitoring respiratory diseases using detailed, regional lung function insights from CT scan data.
Company	3D Systems	Fluidda
Core Imaging Functionality	Converts 2D DICOM to 3D models, automatic/manual segmentation (deep learning driven), 3D model editing, Virtual Reality (VR) visualization for non-diagnostic use.	Functional Respiratory Imaging (FRI), Quantitative HRCT analysis, Regional lung function visualization, 3D segmentation and isolation of sub-compartments.
Target Medical Specialties	Neurosurgery, Orthopedics, Radiology	Pulmonology, Radiology
Supported Imaging Modalities	CT, MR, CBCT	CT scan data

Videos

Demos, reviews, and walkthroughs featuring D2P and Broncholab.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How would each tool specifically enhance or alter my current clinical workflow for patient assessment and planning?

D2P enhances workflows by converting 2D medical images into accurate 3D digital anatomical models, facilitating advanced visualization and surgical planning for neurosurgery and orthopedics. It allows for the creation of patient-specific models and virtual reality visualization for non-diagnostic use, streamlining pre-operative preparation. Broncholab alters workflows by providing AI-powered Functional Respiratory Imaging from CT scans, offering detailed regional lung function insights for pulmonology and radiology. This enables more precise diagnosis, monitoring of disease progression, and support for therapy optimization in respiratory diseases.

Can you elaborate on the clinical accuracy and sensitivity of the 3D models generated by D2P for surgical planning, or the functional respiratory insights provided by Broncholab for diagnosis and monitoring?

D2P utilizes deep learning for automatic and manual segmentation, aiming for accurate 3D digital anatomical models from DICOM data, which are crucial for precise surgical planning in specialties like neurosurgery and orthopedics. Its tools allow for detailed editing to ensure high-quality volume rendering and mesh coloring. Broncholab provides quantitative HRCT analysis and Functional Respiratory Imaging to deliver detailed, regional lung function insights, which are critical for diagnosing and monitoring respiratory diseases. This platform supports disease progression monitoring and therapy optimization, suggesting a focus on clinically relevant and sensitive functional data.

Beyond the listed specialties, what specific clinical scenarios or patient populations would most benefit from the unique capabilities of D2P versus Broncholab?

D2P would particularly benefit complex surgical cases requiring intricate anatomical understanding, such as reconstructive surgery or tumor resections, where patient-specific 3D models and VR visualization can significantly aid planning. It is ideal for scenarios where physical models or advanced visualization improve surgical confidence and outcomes. Broncholab is best suited for patients with chronic or complex respiratory conditions, such as COPD or asthma, where regional lung function insights are crucial for personalized treatment and monitoring disease progression. It offers value in scenarios where standard spirometry may underestimate disease severity.

What is the expected learning curve for a physician and their support staff to effectively utilize each tool, and what is the typical time-to-value for integrating these insights into patient care?

D2P involves learning DICOM viewing, segmentation tools (both automatic and manual), and 3D model editing, which may require dedicated training for proficiency in creating high-quality anatomical models. Time-to-value would depend on the complexity of cases and integration into existing 3D printing or surgical planning workflows, with D2P aiming to minimize technical expertise needed. Broncholab, as an AI-powered diagnostic platform, would involve learning to interpret Functional Respiratory Imaging (FRI) and quantitative HRCT analysis results. The time-to-value could be relatively quick once staff are trained on interpreting the regional lung function insights for immediate diagnostic and monitoring applications.

What are the capabilities for integrating the output or insights from each tool directly into our existing Electronic Health Record (EHR) system to ensure seamless data flow and documentation?

D2P allows the export of 3D digital models in various file formats like STL, OBJ, and PLY, which can then be manually imported or attached to patient records within an EHR system. While direct integration isn't specified, the output is highly compatible for documentation. Broncholab, as an online platform/web portal, likely generates comprehensive reports based on its Functional Respiratory Imaging and quantitative HRCT analysis. These reports would typically be downloaded and attached to the patient's record in the EHR, facilitating documentation of detailed lung function insights.

What specific audit-trail functionalities does each tool offer to track user actions and data modifications, and what additional security protocols are implemented to protect patient data beyond standard regulatory compliance?

D2P operates within a regulated medical device context, implying inherent controls for data handling and potentially some level of traceability for model creation and editing. Specific audit-trail features beyond this are not detailed, but its nature as a workstation-based software suggests local data management. Broncholab, as an online SaaS platform handling protected health information, likely incorporates robust logging and audit trails to track user access and data processing activities. While specific additional security protocols are not detailed, its cloud-based nature typically necessitates advanced data encryption and access controls.

For a multi-site healthcare system, what are the primary considerations for rolling out each tool, and what level of implementation and ongoing technical support can we expect?

Rolling out D2P across multiple sites would involve managing workstation-based software installations and ensuring consistent training for segmentation and 3D model creation teams. Support would likely focus on software functionality and integration with 3D Systems printers and software. For Broncholab, a multi-site rollout would primarily involve user account setup and training for accessing and interpreting the online platform's Functional Respiratory Imaging data. Support would likely cover platform access, data interpretation, and integration of diagnostic insights into clinical practice across various sites.